BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22009531)

  • 1. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.
    Dhar SK; Tangpong J; Chaiswing L; Oberley TD; St Clair DK
    Cancer Res; 2011 Nov; 71(21):6684-95. PubMed ID: 22009531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exposure to 12-O-tetradecanoylphorbol-13-acetate represses sod2 induction in vivo: the negative role of p50.
    Dhar SK; Xu Y; Noel T; St Clair DK
    Carcinogenesis; 2007 Dec; 28(12):2605-13. PubMed ID: 17652337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
    Shibata MA; Ward JM; Green JE; Merlino G
    Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
    Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D
    Cancer Res; 2001 Aug; 61(16):6082-8. PubMed ID: 11507057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression.
    Dhar SK; Xu Y; Chen Y; St Clair DK
    J Biol Chem; 2006 Aug; 281(31):21698-21709. PubMed ID: 16740634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor kappaB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene.
    Dhar SK; Xu Y; St Clair DK
    J Biol Chem; 2010 Mar; 285(13):9835-9846. PubMed ID: 20061391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent genetic control of early and late stages of chemically induced skin tumors in a cross of a Japanese wild-derived inbred mouse strain, MSM/Ms.
    Okumura K; Sato M; Saito M; Miura I; Wakana S; Mao JH; Miyasaka Y; Kominami R; Wakabayashi Y
    Carcinogenesis; 2012 Nov; 33(11):2260-8. PubMed ID: 22843548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
    Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
    Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model.
    Zhao Y; Oberley TD; Chaiswing L; Lin SM; Epstein CJ; Huang TT; St Clair D
    Oncogene; 2002 May; 21(24):3836-46. PubMed ID: 12032821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ; Singh KP
    Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multihit, multistage model of chemical carcinogenesis.
    Owens DM; Wei S; Smart RC
    Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression during tumor promotion and progression in the mouse skin model.
    Bowden GT; Ostrowski LE; Bonham K; Krieg P
    Basic Life Sci; 1991; 57():127-40; discussion 140-1. PubMed ID: 1667569
    [No Abstract]   [Full Text] [Related]  

  • 18. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
    Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M
    Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
    Hennings H
    Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.